PHARMA MAR, S.A. (PMRA.F)

Every figure this model derived for PMRA.F, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 15,015,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 63,239,000 CashAndCashEquivalents 2025-01-01
current assets 250,248,000 CurrentAssets 2025-01-01
current liabilities 82,694,000 CurrentLiabilities 2025-01-01
equity 208,359,000 EquityAttributableToOwnersOfParent 2025-01-01
interest expense 8,528,000 FinanceCosts 2024-12-31
ocf 6,027,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 174,855,000 RevenueFromContractsWithCustomers 2024-12-31
sbc 0 AdjustmentsForSharebasedPayments 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up PMRA.F on one particular measure came for.

RatioValue
cash operating margin3.7
current ratio3.03
current ratio reported3.03
fcf margin-5.14
interest cover0.76
operating margin3.7
owner earnings margin-5.14
revenue growth10.56
revenue growth per share10.56
roic2.76
rule of 4014.26
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about PMRA.F's figures. Written by the derivation as it ran, not added afterwards.